Moderna
Moderna
Moderna Teams Up for Biotech Breakthroughs and Rare Diseases
BIOT
🌱 Moderna teams up with Form Bio and Ginkgo Bioworks to advance biotechnology roots, focusing on mRNA therapeutics and vaccines. 🧬🌍 Researchers also prioritize rare autoimmune diseases for better patient outcomes.
Revolutionizing Nucleic Acid Manufacturing with Digital Innovation
BIOT
📰 Scientists at Penn State highlight the need for digital innovation to enhance nucleic acid manufacturing efficiency. 💡💻🧬
Moderna’s $900m Investment for Global Biotech Growth
BIOT
💰 Moderna plans to invest $900m in capital expenditures in 2024 to support growth ambitions in biotechnology. 🔬🌍⚙️💉
